Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1981 1
1985 3
1986 6
1987 6
1988 3
1989 1
1990 4
1991 7
1992 8
1993 8
1994 8
1995 10
1996 10
1997 6
1998 10
1999 8
2000 4
2001 4
2002 9
2003 3
2004 3
2005 11
2006 4
2007 1
2008 1
2009 2
2010 3
2011 4
2012 2
2013 4
2014 4
2015 1
2016 4
2018 2
2019 2
2020 5
2021 2
2022 2
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Results by year

Filters applied: . Clear all
Page 1
Autoimmune manifestations associated with myelodysplastic syndromes.
Grignano E, Jachiet V, Fenaux P, Ades L, Fain O, Mekinian A. Grignano E, et al. Ann Hematol. 2018 Nov;97(11):2015-2023. doi: 10.1007/s00277-018-3472-9. Epub 2018 Aug 8. Ann Hematol. 2018. PMID: 30091023 Free article. Review.
Autoimmune disorders (ADs) are encountered in 10 to 20% of patients with myelodysplastic syndromes (MDS). Available data suggest that ADs concern more often younger patients with higher risk IPSS. MDS subtypes associated with ADs are mainly MDS with single lineage dysplasi …
Autoimmune disorders (ADs) are encountered in 10 to 20% of patients with myelodysplastic syndromes (MDS). Available data suggest that …
How we manage adults with myelodysplastic syndrome.
Fenaux P, Platzbecker U, Ades L. Fenaux P, et al. Br J Haematol. 2020 Jun;189(6):1016-1027. doi: 10.1111/bjh.16206. Epub 2019 Sep 30. Br J Haematol. 2020. PMID: 31568568 Free article. Review.
The prognosis in Myelodysplastic syndromes (MDS), although recently refined by molecular studies, remains largely based on conventional prognostic scores [International Prognostic Scoring System (IPSS), revised IPSS], classifying patients into "lower risk" MDS (LR-MDS) and …
The prognosis in Myelodysplastic syndromes (MDS), although recently refined by molecular studies, remains largely based on convention …
MDS overlap disorders and diagnostic boundaries.
Tanaka TN, Bejar R. Tanaka TN, et al. Blood. 2019 Mar 7;133(10):1086-1095. doi: 10.1182/blood-2018-10-844670. Epub 2019 Jan 22. Blood. 2019. PMID: 30670443 Free article. Review.
Myelodysplastic syndromes (MDS) are clonal diseases defined by clinical, morphologic, and genetic features often shared by related myeloid disorders. ...Genetic studies have demonstrated that sAML clones can precede clinical progression from MDS by many months, suggesting …
Myelodysplastic syndromes (MDS) are clonal diseases defined by clinical, morphologic, and genetic features often shared by related my …
How I treat myelodysplastic syndromes of childhood.
Locatelli F, Strahm B. Locatelli F, et al. Blood. 2018 Mar 29;131(13):1406-1414. doi: 10.1182/blood-2017-09-765214. Epub 2018 Feb 8. Blood. 2018. PMID: 29438960 Free article. Review.
Pediatric myelodysplastic syndromes (MDSs) are a heterogeneous group of clonal disorders with an annual incidence of 1 to 4 cases per million, accounting for less than 5% of childhood hematologic malignancies. ...Allogeneic hematopoietic stem cell transplantation (HSCT) is …
Pediatric myelodysplastic syndromes (MDSs) are a heterogeneous group of clonal disorders with an annual incidence of 1 to 4 cases per …
The 5q-anomaly.
Van den Berghe H, Vermaelen K, Mecucci C, Barbieri D, Tricot G. Van den Berghe H, et al. Cancer Genet Cytogenet. 1985 Jul;17(3):189-255. doi: 10.1016/0165-4608(85)90016-0. Cancer Genet Cytogenet. 1985. PMID: 3891074 Review.
Variant breakpoints occur in less than 10% of all cases. As the sole anomaly, 5q- is characteristically found in refractory anemia with or without excess of blasts. It can occur as the sole anomaly in de novo or secondary acute nonlymphocytic leukemia, …
Variant breakpoints occur in less than 10% of all cases. As the sole anomaly, 5q- is characteristically found in refractory anemia …
[Myelodysplastic syndrome classification].
Ghariani I, Braham N, Hassine M, Kortas M. Ghariani I, et al. Ann Biol Clin (Paris). 2013 Mar-Apr;71(2):139-44. doi: 10.1684/abc.2013.0804. Ann Biol Clin (Paris). 2013. PMID: 23587576 Free article. Review. French.
Myelodysplastic syndromes (MDS) are myeloid disorders with various clinical and biological presentations. ...The following subgroups are defined: refractory cytopenia with unilineage dysplasia, refractory anemia with ringed sideroblasts, refractory …
Myelodysplastic syndromes (MDS) are myeloid disorders with various clinical and biological presentations. ...The following subgroups …
Myelodysplastic and myeloproliferative disorders of childhood.
Hasle H. Hasle H. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):598-604. doi: 10.1182/asheducation-2016.1.598. Hematology Am Soc Hematol Educ Program. 2016. PMID: 27913534 Free PMC article. Review.
Myelodysplastic syndrome (MDS) and myeloproliferative disorders are rare in children; they are divided into low-grade MDS (refractory cytopenia of childhood [RCC]), advanced MDS (refractory anemia with excess blasts in transformati …
Myelodysplastic syndrome (MDS) and myeloproliferative disorders are rare in children; they are divided into low-grade MDS ( …
Coexistence of plasma cell neoplasia and myelodysplastic syndrome with excess blasts: case reports and literature review.
Yan W, Qu XY, Li H, Li YC, Li Y, Yao K, Yang W, Wang HH. Yan W, et al. Ann Palliat Med. 2021 Dec;10(12):12431-12440. doi: 10.21037/apm-21-3210. Ann Palliat Med. 2021. PMID: 35016480 Free article. Review.
BACKGROUND: The coexistence of plasma cell neoplasia such as multiple myeloma (MM) or monoclonal gammopathy of underdetermined significance (MGUS) with myeloid neoplasia such as myelodysplastic syndrome with excess blasts (MDS-EB) is exceedingly rare. …
BACKGROUND: The coexistence of plasma cell neoplasia such as multiple myeloma (MM) or monoclonal gammopathy of underdetermined significance …
Myelodysplastic Syndrome with t(1;14),t(1;17),t(1;19) Transforms to AML-M5: A Case Report and Literature Review.
Zhang H, Li G, Chang J, Wang H. Zhang H, et al. Ann Clin Lab Sci. 2020 May;50(3):401-403. Ann Clin Lab Sci. 2020. PMID: 32581034 Review.
Chromosomal aberrations play an important role in the incidence of myelodysplastic syndromes (MDS) and development to acute myeloid leukemia (AML). We report a case of a 62-year-old male patient diagnosed with MDS with excess blasts. The karyotype was 45, XY, …
Chromosomal aberrations play an important role in the incidence of myelodysplastic syndromes (MDS) and development to acute myeloid l …
Myelodysplastic syndromes.
Sultan C, Imbert M, Jouault H, Scoazec JY. Sultan C, et al. Acta Haematol. 1987;78 Suppl 1:91-3. doi: 10.1159/000205910. Acta Haematol. 1987. PMID: 3124454 Review.
The myelodysplastic syndromes (MDS) represent a group of syndromes having in common a defective production of one or more myeloid cell lines. ...Some syndromes are easily recognizable such as acquired idiopathic sideroblastic anemia, refractory anemia …
The myelodysplastic syndromes (MDS) represent a group of syndromes having in common a defective production of one or more myeloid cel …
172 results